Domestic: | 1-888-886-7786 |
International: | 1-416-764-8658 |
Conference ID: | 08695074 |
Webcast: | Webcast Link |
About
Investor Contact:
Managing Director
daniel@lifesciadvisors.com
(617) 430-7576
Source:
2024 GlobeNewswire, Inc., source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.31 USD | +2.31% | +0.57% | +41.22% |
Apr. 15 | CorMedix's DefenCath Now Commercially Available For US Inpatient Use | MT |
Apr. 15 | CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath®? (Taurolidine and Heparin) | CI |
Domestic: | 1-888-886-7786 |
International: | 1-416-764-8658 |
Conference ID: | 08695074 |
Webcast: | Webcast Link |
About
Investor Contact:
Managing Director
daniel@lifesciadvisors.com
(617) 430-7576
Source:
2024 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
+41.22% | 292M | |
+5.31% | 70.44B | |
+10.97% | 8.94B | |
-16.83% | 4.75B | |
+43.48% | 4.5B | |
+3.20% | 3.85B | |
-21.36% | 2.34B | |
-29.67% | 2.2B | |
+8.38% | 1.96B | |
+3.90% | 1.65B |